comparemela.com

Latest Breaking News On - Neurological science - Page 2 : comparemela.com

The Oligonucleotide Therapeutics Society Celebrates Another

The Oligonucleotide Therapeutics Society Celebrates Another Remarkable Annual Meeting | Comunicados | Edición USA

The Oligonucleotide Therapeutics Society Celebrates Another Remarkable Annual Meeting | Comunicados | Edición USA
efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.

The Oligonucleotide Therapeutics Society Celebrates Another Remarkable Annual Meeting

SAN DIEGO, Oct. 09, 2021was held virtually the second year in a row and was once again phenomenally successful. Over 1,000 attendees around the world engaged in lively discussions and learned about groundbreaking

Membership - Commission on Human Medicines

Membership - Commission on Human Medicines
gov.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gov.uk Daily Mail and Mail on Sunday newspapers.

OSF HealthCare Foundation Receives Million Dollar Gift

A $1 million donation to the OSF HealthCare Foundation will support neuroscience innovation. The gift is from former Caterpillar Group President Ed Rapp and his wife Ann. Ed Rapp was diagnosed with ALS - or Lou Gehrig s disease - and has focused his retirement efforts on finding a cure. The gift comes after the Rapps created an OSF HealthCare endowment last year. It funds innovation efforts aimed at earlier disease diagnoses and improving assistive technologies. The newest donation will support collaborative research efforts between OSF HealthCare Illinois Neurological Institute, Jump Simulation and University of Illinois engineers. OSF says more than 12 million Americans are projected to suffer from degenerative or autoimmune disorders including ALS, dementia, Parkinson’s disease and Multiple Sclerosis within the next 30 years.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.